好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Safety of Therapeutic Anticoagulation for Deep Venous Thrombosis/Pulmonary Embolus (DVT/PE) and the Rsk of Recurrent DVT/PE in Glioma Patients Receiving Bevacixumab-Based Therapy: The CNOG Experience
Neurometabolic Disorders/Neurotoxicology/Neuroendocrinology
(-)
006
Authors/Disclosures
Lisa R. Rogers, DO, FAAN (Henry Ford Hospital) Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Mark G. Malkin, MD, FAAN (CLEVELAND CLINIC) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Hendrikus G. Krouwer, MD, PhD (UW Cancer Center At ProHealth Care) No disclosure on file
Larry Junck, MD Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Junck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier Pharmaceuticals, LLC. Dr. Junck has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bowman & Brooke.
No disclosure on file
Martin K. Nicholas, MD (University of Illinois) No disclosure on file
Nina Paleologos, MD No disclosure on file